Samedi, 23 Juin 2018
Dernières nouvelles
Principale » Is Buying Healthequity Inc (HQY) Here a Winning Strategy?

Is Buying Healthequity Inc (HQY) Here a Winning Strategy?

09 Juillet 2017

The shares were sold at an average price of $52.80, for a total transaction of $13,112,932.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

In related news, VP Darcy G. Mott sold 10,000 shares of the business's stock in a transaction on Thursday, April 20th. The stock was sold at an average price of $50.40, for a total transaction of $428,400.00. Also, EVP Delano Ladd sold 1,095 shares of the business's stock in a transaction on Thursday, April 13th. The shares were sold at an average price of $51.99, for a total transaction of $208,063.98. Chardan Capital Markets initiated the shares of HQY in report on Tuesday, December 13 with "Buy" rating. The shares were sold at an average price of $46.18, for a total transaction of $55,416.00.

On Friday, June 23rd, Berkley Capital, Llc sold 54,967 shares of HealthEquity stock. The shares were sold at an average price of $51.78, for a total transaction of $2,846,191.26. The shares were sold at an average price of $51.86, for a total transaction of $1,089,060.00. Stephens Investment Management Group Llc who had been investing in Healthequity Inc for a number of months, seems to be less bullish one the $2.78 billion market cap company.

More recent Healthequity Inc (NASDAQ:HQY) news were published by: Nasdaq.com which released: "Healthequity Inc (HQY) President and CEO Jon Kessler Sold $7.5 million of Shares" on June 10, 2017. Court Place Advisors Llc acquired 12,515 shares as Unilever Plc (UL)'s stock rose 11.00%. The company has a market capitalization of $2.90 billion, a PE ratio of 90.79 and a beta of 1.79. The stock's 50-day moving average price is $47.55 and its 200-day moving average price is $44.59. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.03. The firm had revenue of $55.40 million during the quarter, compared to analysts' expectations of $54.77 million. The business's revenue was up 25.9% compared to the same quarter past year. During the same period in the previous year, the firm earned $0.15 EPS.

On average, analysts expect that HealthEquity will report full year earnings of $0.58 per share for the current year, with EPS estimates ranging from $0.54 to $0.59. Robert W. Baird maintained Healthequity Inc (NASDAQ:HQY) on Wednesday, September 7 with "Neutral" rating. "(NASDAQ:HQY) Major Shareholder Berkley Capital, Llc Sells 56,067 Shares" was reported by Transcript Daily and is the property of of Transcript Daily. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of U.S. & worldwide trademark & copyright legislation. The correct version of this story can be viewed at https://baseballnewssource.com/markets/stephen-neeleman-sells-40000-shares-of-healthequity-inc-hqy-stock-updated-updated-updated/946406.html.

Watch Australian journalist's viral roast of Donald Trump at G20 summit
ABC journalist Chris Uhlmann has delivered a scathing assessment of Donald Trump's presidency. And that is the biggest threat to the values of the West which he claims to hold so dear.

HQY has been the topic of several recent research reports. J P Morgan Chase & Co upped their price target on shares of HealthEquity from $44.00 to $51.00 and gave the company an "overweight" rating in a report on Wednesday, March 22nd. Chardan Capital Markets maintained the shares of HQY in report on Wednesday, March 22 with "Buy" rating. Wells Fargo & Company initiated coverage on shares of HealthEquity in a report on Tuesday, March 14th. As per Tuesday, October 13, the company rating was initiated by TheStreet. Oppenheimer Holdings, Inc. reaffirmed an "outperform" rating and issued a $61.00 price objective (up previously from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. Finally, Cantor Fitzgerald started coverage on HealthEquity in a research note on Thursday, March 30th. They issued an "overweight" rating and a $50.00 price objective on the stock.

Among 11 analysts covering Unilever (NYSE:UL), 4 have Buy rating, 1 Sell and 6 Hold. The stock of Healthequity Inc (NASDAQ:HQY) earned "Buy" rating by Suntrust Robinson on Wednesday, June 8.

A number of large investors have recently modified their holdings of the company. Comerica Bank raised its stake in HealthEquity by 5.7% in the fourth quarter. Fifth Third Bancorp now owns 2,414 shares of the company's stock valued at $102,000 after buying an additional 1,914 shares during the last quarter.

HealthEquity Inc had 19 analyst reports since August 18, 2015 according to SRatingsIntel. Fifth Third Bancorp boosted its position in HealthEquity by 382.8% in the first quarter. Arcadia Investment Management Corp MI now owns 2,515 shares of the company's stock worth $107,000 after buying an additional 1,131 shares during the period. FMR LLC raised its position in HealthEquity by 119.9% in the fourth quarter.

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators.